Science & Technology
Phase I Therapeutic Award: a Novel Engineered Bacterial Anticancer Immunotherapy for Merkel Cell Carcinoma
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N91024C00006
Award Ceiling
$355K
Award Floor
$355K
Close Date
N/A
Total Funding
$355K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N91024C00006
Description
SBIR Phase Phase I award: "PHASE I THERAPEUTIC AWARD: A NOVEL ENGINEERED BACTERIAL ANTICANCER IMMUNOTHERAPY FOR MERKEL CELL CARCINOMA" awarded to TRANQUILITY BIODESIGN LLC in Houston, Texas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $354,996. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.